ICPT · Categories · Form 4

ICPT - SEC Form 4 insider transactions

Intercept Pharmaceuticals Inc. (ICPT) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for ICPT

• 940d
  Akkaraju Srinivas returned $154,109 worth of shares to the company (8,111 units at $19.00), closing all direct ownership in the company (SEC Form 4)

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 940d
  Fundaro Paolo returned $154,109 worth of shares to the company (8,111 units at $19.00), closing all direct ownership in the company (SEC Form 4)

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 940d
  Venezia Rocco returned $278,711 worth of shares to the company (14,669 units at $19.00), closing all direct ownership in the company (SEC Form 4)

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 940d
  Berrey M Michelle returned $984,010 worth of shares to the company (51,790 units at $19.00), closing all direct ownership in the company (SEC Form 4)

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 940d
  Richardson Linda M returned $505,115 worth of shares to the company (26,585 units at $19.00), closing all direct ownership in the company (SEC Form 4)

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 940d
  Benatti Luca returned $154,109 worth of shares to the company (8,111 units at $19.00), closing all direct ownership in the company (SEC Form 4)

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 940d
  Sblendorio Glenn returned $154,109 worth of shares to the company (8,111 units at $19.00), closing all direct ownership in the company (SEC Form 4)

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 940d
  Miller-Rich Nancy returned $154,109 worth of shares to the company (8,111 units at $19.00), closing all direct ownership in the company (SEC Form 4)

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 940d
  Santini Gino returned $154,109 worth of shares to the company (8,111 units at $19.00), closing all direct ownership in the company (SEC Form 4)

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 940d
  Rosa-Bjorkeson Dagmar returned $220,875 worth of shares to the company (11,625 units at $19.00), closing all direct ownership in the company (SEC Form 4)

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 940d
  Gottesdiener Keith Michael returned $154,109 worth of shares to the company (8,111 units at $19.00), closing all direct ownership in the company (SEC Form 4)

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 940d
  Ford David A returned $406,600 worth of shares to the company (21,400 units at $19.00), closing all direct ownership in the company (SEC Form 4)

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 940d
  Freedberg Jared returned $641,478 worth of shares to the company (33,762 units at $19.00), closing all direct ownership in the company (SEC Form 4)

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 940d
  Bradbury Daniel returned $154,109 worth of shares to the company (8,111 units at $19.00), closing all direct ownership in the company (SEC Form 4)

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 940d
  Durso Jerome Benedict returned $1,953,675 worth of shares to the company (102,825 units at $19.00), closing all direct ownership in the company (SEC Form 4)

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 940d
  Pruzanski Mark closing all direct ownership in the company (SEC Form 4)

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 940d
  Saik Andrew returned $859,636 worth of shares to the company (45,244 units at $19.00), closing all direct ownership in the company (SEC Form 4)

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 950d
  Freedberg Jared covered exercise/tax liability with 771 shares, decreasing direct ownership by 1% to 56,443 units (SEC Form 4)

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 989d
  SEC Form 4: Saik Andrew covered exercise/tax liability with 908 shares, decreasing direct ownership by 1% to 68,265 units

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 996d
  SEC Form 4: Berrey M Michelle covered exercise/tax liability with 1,246 shares, decreasing direct ownership by 2% to 80,139 units

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 1042d
  SEC Form 4: Freedberg Jared covered exercise/tax liability with 771 shares, decreasing direct ownership by 1% to 57,214 units

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 1083d
  SEC Form 4 filed by Saik Andrew

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 1090d
  SEC Form 4 filed by Berrey M Michelle

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 1112d
  SEC Form 4 filed by Benatti Luca

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 1112d
  SEC Form 4 filed by Sblendorio Glenn

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 1112d
  SEC Form 4 filed by Gottesdiener Keith Michael

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 1112d
  SEC Form 4 filed by Fundaro Paolo

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 1112d
  SEC Form 4 filed by Santini Gino

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 1112d
  SEC Form 4 filed by Rosa-Bjorkeson Dagmar

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 1112d
  SEC Form 4 filed by Miller-Rich Nancy

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 1112d
  SEC Form 4 filed by Bradbury Daniel

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 1112d
  SEC Form 4 filed by Akkaraju Srinivas

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 1134d
  SEC Form 4 filed by Freedberg Jared

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 1175d
  SEC Form 4 filed by Saik Andrew

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 1182d
  SEC Form 4: Berrey M Michelle covered exercise/tax liability with 1,246 shares, decreasing direct ownership by 1% to 82,631 units

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 1210d
  SEC Form 4: Richardson Linda M covered exercise/tax liability with 386 shares, decreasing direct ownership by 0.88% to 43,291 units

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 1223d
  SEC Form 4: Freedberg Jared covered exercise/tax liability with 918 shares, decreasing direct ownership by 2% to 58,756 units

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 1226d
  SEC Form 4: Venezia Rocco was granted 9,800 shares, increasing direct ownership by 63% to 25,451 units

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 1226d
  SEC Form 4: Saik Andrew was granted 14,700 shares, increasing direct ownership by 26% to 70,990 units

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 1226d
  SEC Form 4: Richardson Linda M was granted 12,200 shares, increasing direct ownership by 39% to 43,677 units

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 1226d
  SEC Form 4: Freedberg Jared was granted 12,200 shares, increasing direct ownership by 26% to 59,674 units

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 1226d
  SEC Form 4: Ford David A was granted 9,800 shares, increasing direct ownership by 37% to 36,438 units

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 1226d
  SEC Form 4: Durso Jerome Benedict was granted 50,400 shares, increasing direct ownership by 48% to 154,640 units

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 1226d
  SEC Form 4: Berrey M Michelle was granted 14,700 shares, increasing direct ownership by 21% to 83,877 units

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 1254d
  SEC Form 4: Venezia Rocco covered exercise/tax liability with 675 shares, decreasing direct ownership by 4% to 15,651 units

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 1254d
  SEC Form 4: Saik Andrew covered exercise/tax liability with 718 shares, decreasing direct ownership by 1% to 56,290 units

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 1254d
  SEC Form 4: Freedberg Jared covered exercise/tax liability with 718 shares, decreasing direct ownership by 1% to 47,474 units

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 1254d
  SEC Form 4: Richardson Linda M covered exercise/tax liability with 1,600 shares, decreasing direct ownership by 5% to 31,477 units

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 1254d
  SEC Form 4: Ford David A covered exercise/tax liability with 1,777 shares, decreasing direct ownership by 6% to 26,638 units

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 1254d
  SEC Form 4: Durso Jerome Benedict covered exercise/tax liability with 7,083 shares, decreasing direct ownership by 6% to 104,240 units

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 1254d
  SEC Form 4: Berrey M Michelle covered exercise/tax liability with 765 shares, decreasing direct ownership by 1% to 69,177 units

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 1265d
  SEC Form 4: Saik Andrew covered exercise/tax liability with 908 shares, decreasing direct ownership by 2% to 57,008 units

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 1272d
  SEC Form 4: Berrey M Michelle covered exercise/tax liability with 1,246 shares, decreasing direct ownership by 2% to 69,942 units

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 1315d
  SEC Form 4: Freedberg Jared covered exercise/tax liability with 771 shares, decreasing direct ownership by 2% to 48,192 units

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 1356d
  SEC Form 4: Saik Andrew covered exercise/tax liability with 908 shares, decreasing direct ownership by 2% to 57,916 units

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 1363d
  SEC Form 4: Berrey M Michelle covered exercise/tax liability with 1,246 shares, decreasing direct ownership by 2% to 71,188 units

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 1373d
  SEC Form 4: Venezia Rocco covered exercise/tax liability with 429 shares, decreasing direct ownership by 3% to 16,326 units

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 1373d
  SEC Form 4: Richardson Linda M covered exercise/tax liability with 597 shares, decreasing direct ownership by 2% to 33,077 units

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 1393d
  SEC Form 4: Richardson Linda M covered exercise/tax liability with 124 shares, decreasing direct ownership by 0.37% to 33,674 units

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 1407d
  SEC Form 4: Freedberg Jared covered exercise/tax liability with 771 shares, decreasing direct ownership by 2% to 48,963 units

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)

Other ICPT categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends